Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotechnology company focused on developing innovative therapies for serious diseases with unmet medical needs, today announced that U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback